GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$78.29
+0.22%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.1B | 2.9B | 2.5B | 1.6B | 1.0B |
| Cost of Revenue | 989.1M | 957.8M | 1.0B | 548.2M | 263.7M |
| Gross Profit | 2.2B | 2.0B | 1.5B | 1.0B | 759.1M |
| Operating Expenses | |||||
| R&D Expense | 184.8M | 185.0M | 163.8M | 124.0M | 73.0M |
| SG&A Expense | 1.4B | 1.3B | 981.0M | 643.4M | 432.1M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (34.6M) | — | 173.1M | 119.7M | 26.0M |
| Total Operating Expenses | 1.5B | 1.5B | 1.3B | 887.2M | 531.2M |
| Cost and Expenses | 2.5B | 2.5B | 2.4B | 1.4B | 794.9M |
| Operating Income (EBIT) | 652.7M | 479.8M | 166.0M | 133.1M | 228.0M |
| Non-Operating | |||||
| Interest Income | 10.2M | 7.1M | — | 20.1M | 14.2M |
| Interest Expense | — | — | 4.2M | — | — |
| Net Interest Income | 10.2M | 7.1M | (4.2M) | 20.1M | 14.2M |
| Other Non-Op Income/Expense | 12.3M | 130.1M | (45.3M) | 32.3M | 15.1M |
| Non-Operating Income (excl Interest) | (12.3M) | (130.1M) | (53.7M) | (68.7M) | (8.3M) |
| EBT (Pre-Tax Income) | 665.0M | 609.9M | 120.7M | 165.4M | 243.0M |
| Income Tax Expense | 129.5M | 72.0M | 17.7M | 42.5M | 52.9M |
| Bottom Line | |||||
| Net Income | 535.5M | 537.9M | 103.0M | 122.9M | 190.2M |
| Earnings from Cont. Ops | 535.5M | 537.9M | 103.0M | 122.9M | 190.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 535.5M | 537.9M | 103.0M | 122.9M | 190.2M |
| Per Share | |||||
| Basic EPS | $3.97 | $3.98 | $0.76 | $1.09 | $1.89 |
| Diluted EPS | $3.89 | $3.92 | $0.75 | $1.07 | $1.85 |
| Revenue Per Share | $23.23 | $21.75 | $18.56 | $13.87 | $10.18 |
| Shares | |||||
| Basic Shares Outstanding | 135.4M | 135.2M | 135.7M | 113.1M | 100.5M |
| Diluted Shares Outstanding | 138.2M | 137.2M | 137.9M | 114.6M | 102.6M |
| Profitability Metrics | |||||
| EBITDA | 876.3M | 729.9M | 473.7M | 346.6M | 304.5M |
| D&A | 211.3M | 120.0M | 254.0M | 144.7M | 68.3M |
| EBIT | 665.0M | 609.9M | 219.7M | 201.8M | 236.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026